Is Cryopyrin-associated periodic syndrome hereditary?

TL;DR: Cryopyrin-associated periodic syndrome (CAPS) is a genetic condition caused by mutations in the NLRP3 gene, and it is inherited in an autosomal dominant pattern. This means an affected parent has a 50% chance of passing the mutation to each of their children, though many cases arise from spontaneous de novo mutations in individuals with no family history.

Is Cryopyrin-associated periodic syndrome hereditary?

Cryopyrin-associated periodic syndrome is both genetic and hereditary. Being "genetic" means it is caused by a change in a person's DNA, while being "hereditary" means the mutation can be passed from parents to their children. CAPS is caused by gain-of-function mutations in the NLRP3 gene, which provides instructions for making a protein called cryopyrin. This protein is a key component of the inflammasome, a cellular structure that triggers inflammation. When the NLRP3 gene is mutated, the inflammasome becomes overactive, leading to the systemic inflammation characteristic of Cryopyrin-associated periodic syndrome.

What is the inheritance pattern of Cryopyrin-associated periodic syndrome?

Cryopyrin-associated periodic syndrome follows an autosomal dominant inheritance pattern. In this pattern, only one copy of the mutated gene—inherited from either the mother or the father—is sufficient to cause the condition. Because it is autosomal, the gene is located on one of the non-sex chromosomes, meaning it affects males and females equally. For individuals with a confirmed NLRP3 mutation, there is a 50% statistical probability of passing the mutation to each offspring. However, it is important to note that many patients with Cryopyrin-associated periodic syndrome do not have an affected parent; in these cases, the condition is caused by a de novo (spontaneous) mutation that occurred for the first time in the affected individual.

What is the role of genetic testing and counseling?

Genetic testing is the gold standard for confirming a diagnosis of Cryopyrin-associated periodic syndrome. Because the clinical spectrum of CAPS—which includes Familial Cold Autoinflammatory Syndrome (FCAS), Muckle-Wells Syndrome (MWS), and Neonatal-Onset Multisystem Inflammatory Disease (NOMID)—can overlap with other autoinflammatory conditions, molecular confirmation is essential. Genetic counseling is highly recommended for any family navigating a diagnosis. A counselor can help explain the risks to relatives, discuss the implications of de novo mutations, and provide information on reproductive choices.

Key considerations for families

• Genetic Testing: Sequencing of the NLRP3 gene is the primary diagnostic method, though some patients may test negative if they have somatic mosaicism (where the mutation is only present in a subset of cells).


• Reproductive Options: Families may explore options such as preimplantation genetic testing (PGT) during IVF to reduce the risk of passing the mutation to offspring.


• Community Support: At DiseaseMaps.org, 32 people with Cryopyrin-associated periodic syndrome have shared their lived experiences, providing a valuable resource for families seeking peer connection and guidance.


• Clinical Variability: Even within families carrying the same NLRP3 mutation, the severity and specific symptoms of Cryopyrin-associated periodic syndrome can vary significantly between individuals.

Next steps

• Consult with a clinical geneticist to discuss testing options for you and your family members.


• Speak with a rheumatologist or immunologist who specializes in autoinflammatory diseases.


• Connect with the DiseaseMaps.org community to share experiences with others living with Cryopyrin-associated periodic syndrome.


• Request a referral for genetic counseling to discuss family planning and inheritance risks.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare provider for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cryopyrin-associated periodic syndrome.


• Orphanet: Cryopyrin-associated periodic syndrome (ORPHA: 32490).


• OMIM (Online Mendelian Inheritance in Man): NLRP3-related autoinflammatory disease (Entry #120100).


• The Autoinflammatory Alliance: Patient resources and disease education.